Biostatistics Director
Company | Exelixis |
---|---|
Location | King of Prussia, PA, USA, Alameda, CA, USA |
Salary | $187500 – $266000 |
Type | Full-Time |
Degrees | Bachelor’s, Master’s, PhD |
Experience Level | Senior, Expert or higher |
Requirements
- BS/BA degree in Statistics/Biostatistics or related discipline and a minimum of thirteen years of related experience; or,
- MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of eleven years of related experience; or,
- PhD in Statistics/Biostatistics or related discipline and a minimum of eight years of related experience; or,
- Equivalent combination of education and experience.
- May require certification in assigned area.
Responsibilities
- Work with department head to develop and implement department standards and practices.
- Direct the statistical design, conduct, and analysis of clinical trials in all phases.
- Review protocols and case report forms for soundness of trial design.
- Review and or author statistical analysis plans for all phases of a trial.
- Perform analysis, interpret study results, and collaborate with clinical team to produce interim reports, final reports, and publications.
- Direct the development, validation and summary of integrated safety and efficacy summaries.
- Interact with FDA or EU Authority staff to ensure clinical studies meet regulatory requirements.
- Attend meetings with FDA or EU Authority to ensure ongoing agreement on project development.
- Contribute to the development of Requests-for-Proposals.
- Evaluate and manage contract research organizations and other vendors, including scope-of-work, timelines, deliverables and budgets.
- Responsible for all statistical oversight within a therapeutic area.
Preferred Qualifications
- Managed and or supported clinical trials, preferably in the therapeutic area of oncology and in the biotech/pharmaceutical industry.
- Preferably led a phase III clinical trial.
- In-depth knowledge of CDISC standards.
- Management and statistical analysis of data obtained from Phase I – IV clinical studies in support of US NDAs.
- Direct experience with FDA/EU Authority preferred.